Author

Itzamar Torres

Scripps Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Organism:mouse· 3 Approach:statistical model· 3 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Irene LorraiiD· 3 shared Pietro Paolo SannaiD· 3 shared Riccardo MaccioniiD· 3 shared Roberta PuligaiD· 3 shared Vez Repunte‐CanonigoiD· 3 shared Jorge Marquez Gaytan· 2 shared Chase A. ShankulaiD· 1 shared Chenhao Wu· 1 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

9 top collaborators · 34 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

Irene LorraiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

N6-methyladenosine RNA methylation is a novel epitranscriptomic regulator of excessive alcohol drinking and vulnerability to relapse

Riccardo Maccioni, Irene Lorrai, Itzamar Torres, Roberta Puliga, Vez Repunte‐Canonigo, Pietro Paolo Sanna

This study shows that N6-methyladenosine (m6A) RNA methylation regulates alcohol drinking and relapse by altering gene expression in the hippocampus of mice.

bioRxiv · Nov 16, 2025 · PreprintNeuroscience

Gene network inference and master regulator analysis identifies the estrogen-related receptor gamma (ERRγ) as a therapeutic target for alcohol use disorder (AUD).

Irene Lorrai, Riccardo Maccioni, Itzamar Torres, Roberta Puliga, Jorge Marquez Gaytan, Federico Manuel Giorgi, Vez Repunte‐Canonigo, Pietro Paolo Sanna

bioRxiv · Nov 15, 2025 · PreprintNeuroscience

Sphingosine-1-phosphate (S1P) signaling as a novel therapeutic target for alcohol abuse.

Irene Lorrai, Riccardo Maccioni, Chenhao Wu, Chase A. Shankula, Jorge Marquez Gaytan, Itzamar Torres, Roberta Puliga, Vez Repunte‐Canonigo, Pietro Paolo Sanna

This study shows that S1P receptor agonists reduce alcohol drinking in rodent models and identify S1P signaling as a potential therapeutic target for alcohol use disorder.

bioRxiv · Nov 15, 2025 · PreprintNeuroscience